Longevity ≠ Wellness? Someone Has Done an Engineering Breakdown on "Solving Aging" | muShanghai Field Notes

Background

The presentation frames aging not as an inevitable part of life, but as a systemic failure whose root causes are poorly understood. Historically, no major government or institution has made solving aging a strategic priority, creating what LBF identifies as a critical "strategic void." Their mission is to fill this gap by applying a systematic, engineering-minded approach to a biological problem, shifting the perspective from passive acceptance to active intervention.

Key Points

• Aging as an Engineering Problem: The core thesis is to reframe aging from a biological mystery into a set of technical and engineering challenges that can be broken down, funded, and solved through structured projects.
• A Prioritized Hierarchy of Solutions: LBF outlines three strategic paths, ranked by estimated difficulty and capital requirements:
  1. Bioengineering: The most distant goal, requiring a fundamental understanding of aging's causal pathways—a theoretical framework that does not yet exist.
  2. Biostasis: Primarily through cryonics, this aims to "pause" life until bioengineering solutions are available. It's characterized more as an engineering and logistics challenge than a basic science one, though the field suffers from extreme underfunding and few practitioners.
  3. Replacement: This path, which excites LBF the most, involves repairing or replacing damaged components, from cells to whole bodies. Their analysis suggests this could be achievable with significantly less time and cost than solving aging's fundamental biology.
• Existing Technical Milestones: The talk highlighted several real-world developments that support these long-term paths:
  • Reproductive Cloning: The 2018 creation of cloned primates ("Zhong Zhong" and "Hua Hua") is noted as a background milestone in reproductive biology, relevant to concepts like "bodyoid" generation.
  • Commercial Cryopreservation: Companies like Tomorrow.Bio are operational, with hundreds of clients and substantial contract values, demonstrating market validation for biostasis services.
  • Nanowarming: A 2025 proof-of-concept using nanoparticles for rapid, uniform rewarming of vitrified matter addresses a critical technical barrier in organ-scale cryopreservation.
  • Regeneration Research: Studies on mouse digit-tip regeneration show the body's latent capacity for complex tissue repair, providing a biological model for future replacement therapies.
• Distinguishing Health Optimization: The approach is explicitly separated from mere healthspan extension efforts (like those of Brian Johnson), which focus on optimizing biomarkers and lifestyle within a normal lifespan rather than solving the underlying cause of death.

Significance

The LBF framework represents a paradigm shift in how the problem of aging is approached. By moving it from the domain of pure biology into the realm of engineering and project management, it makes the problem seem more tangible, fundable, and solvable. The prioritization of the "Replacement" path is a key insight, suggesting a more pragmatic and potentially faster route than the distant goal of fully understanding aging biology. Furthermore, the compilation of existing technical milestones—from cryonics businesses to regeneration studies—serves to ground these long-term visions in current reality, arguing that the foundational tools are beginning to materialize. This approach seeks to mobilize talent and capital by presenting a credible, phased roadmap toward what was once considered science fiction.